Sanofi is a global biopharmaceutical company that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company’s primary therapeutic areas include diabetes and cardiovascular disease, oncology, immunology, multiple sclerosis, rare diseases and vaccines. Through its Sanofi Genzyme division, the company also focuses on specialty care for rare genetic disorders and immunology, while its Sanofi Pasteur unit is one of the world’s largest vaccine manufacturers, providing immunizations for diseases such as influenza, meningitis and yellow fever.
Founded in its current form in 2004 through the merger of Sanofi-Synthélabo and Aventis, the company traces its roots to 1973 when the original Sanofi was established in France. Over the decades, Sanofi has built a diversified portfolio by combining research-driven acquisitions with internal R&D efforts. The company operates state-of-the-art research centers in France, the United States, Germany and other countries, and collaborates with academic institutions and biotech partners to advance scientific innovation.
Sanofi serves patients and customers in more than 100 countries, with strong commercial operations in Europe, North America, Latin America, Africa and Asia-Pacific. The company maintains a robust presence in emerging markets, where it strives to improve access to medicines and vaccines through targeted programs and partnerships with local governments and health organizations. Sanofi also produces a range of over-the-counter products under well-known consumer brands.
Under the leadership of Chief Executive Officer Paul Hudson, Sanofi continues to prioritize a pipeline of novel therapies and vaccines, investing significantly in research areas such as mRNA technology, monoclonal antibodies and gene therapy. The company’s executive team brings extensive experience in pharmaceutical development, global operations and regulatory affairs, guiding Sanofi’s strategy to address unmet medical needs and deliver sustainable growth in the global healthcare landscape.
AI Generated. May Contain Errors.
